Anavex (AVXL) awaits a key EU ruling on its Alzheimer’s drug. Learn about trial challenges, approval risks, and why a Sell ...
Lilford could not afford a last-minute flight halfway across the world. There’s a market for lending to H-2A workers crunched for time, he said — one dominated by “people doing scams to get your ...